Zomagen Biosciences
Technologiepark 94
9052 Gent
BE
Zomagen Biosciences
Foundation date
26/02/2020
Sector
#Biotechnology - TherapeuticsSubsector
- #Therapeutics - Small molecules
- #Supplier - Chemicals
- #Supplier - Distributors
- #Supplier - Instrumentation
- #Supplier - Laboratory consumables and reagents
- #Supplier - Laboratory equipment
- #Supplier - Medical devices
Therapeutic areas
- #Cardiovascular
- #Diseases of the blood and blood-forming organs - immune disorders
- #Respiratory system
Zomagen is a therapeutic product discovery & development biotech company focussed on compounds targeting the innate immune system, eventually to treat diseases with chronic inflammatory involvement.
Upcoming events
All events-
0106 '23
KNOWLEDGE FOR GROWTH 2023
Event by: flanders.bio -
0506 '23
BIO International Convention 2023
Event by: Biotechnology Innovation Organisation -
2206 '23
Translational Research in Crops
Event by: VIB
Latest news
More news-
Mithra appoints experienced life sciences executive Christian Homsy* as Chairman
1 day ago
Read more
-
Oxurion reaches enrollment target in KALAHARI Phase 2, Part B trial of novel PKal inhibitor THR-149 in diabetic macular edema
Friday May 26th 2023
Read more
-
How garbage disposal clogs in cells can lead to Alzheimer’s
Friday May 26th 2023
Read more